Compare Honeywell International Inc (HON) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Honeywell International Inc vs Marsh & McLennan Companies, Inc. — how do they compare? Honeywell International Inc trades at $207.73 (market cap $65.48B), while Marsh & McLennan Companies, Inc. trades at $175.76 (market cap $84.31B). The key difference: Marsh & McLennan Companies, Inc. is the larger of the two by market cap, and Marsh & McLennan Companies, Inc. pays the higher dividend (2.24%). Which is the better fit depends on your goals — on Pluang, investors hold Honeywell International Inc for 91 Days and Marsh & McLennan Companies, Inc. for 109 Days on average.
| HON | MRSH | |
|---|---|---|
Market Cap | $65.48B | $84.31B |
Volume | 2,047,782 | 3,948,947 |
Sector | Industrials | Financials |
52-Week High | $248.79 | $207.02 |
52-Week Low | $188.14 | $157.32 |
Typical Hold Time | 91 Days | 109 Days |
Enterprise Value | $90.27B | $104.99B |
Dividend Yield | 1.36% | 2.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Honeywell International (HON) trades at $206.6, down 0.73% on the day, with technical indicators showing a bearish trend while maintaining strong fundamental metrics including a low P/E of 7.94 and robust ROE of 47.43%. The company recently secured a $300 million refinery project with Dangote and completed its transformation into a pure-play automation business following corporate spinoffs. Recent quarterly earnings have consistently exceeded expectations, with Q2 2026 EPS of $1.95 beating estimates of $1.80.
Wall Street maintains strong bullish sentiment with 20 buy ratings and a $259.25 consensus price target representing 25% upside potential. Key risks include increasing debt-to-asset ratios (47.66% in 2025) and potential execution challenges in the post-spinoff transition. The company's focused automation strategy and strong profitability metrics support long-term growth prospects despite near-term technical weakness.
Marsh (MRSH) trades at $176.67, up 1.73% today, with a bullish technical trend and strong support at $174. The company shows robust fundamentals, with revenue growing to $26.98B in 2025 and a net income margin of 14.24%. Recent acquisition of Accel Holdings (Business Wire, 2026-10-02) may enhance growth. Earnings have consistently beaten estimates in recent quarters, with Q3 2026 results pending.
Outlook is positive with a consensus price target of $202.71 (MarketBeat, 2026-09-30), offering ~15% upside. Risks include competitive pressures and market volatility. Analyst sentiment is mixed, with 32% buy ratings but 65% hold, suggesting cautious optimism amid solid execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Honeywell International Inc
Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →
